Home > Journals > Minerva Urologica e Nefrologica > Past Issues > Minerva Urologica e Nefrologica 2015 March;67(1) > Minerva Urologica e Nefrologica 2015 March;67(1):55-63

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as

 

REVIEWS   

Minerva Urologica e Nefrologica 2015 March;67(1):55-63

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Robot-assisted surgical approach to bladder cancer: a decade of progress!

Al-Tartir T. 1, Raza S. 1, Alotaibi M. 2, Khan A. 1, Hara I. 3, Fujisawa M. 4, Guru K. 1

1 Urology Department, Roswell Park Cancer Institute, Buffalo, NY, USA; 2 Urology Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; 3 Department of Urology, Wakayama Medical University, Wakayama, Japan; 4 Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan


PDF


Robot-assisted radical cystectomy (RARC) has gained popularity and proven its efficacy, safety and reproducibility in the last decade. RARC has resulted in less blood loss, enhanced recovery, and shorter hospital stay. RARC has proven to have similar or better postoperative morbidity, mortality and equal oncologic, outcomes. Limiting factors to the acceptance of this surgical approach have included its steep learning curve and the lack of both long-term outcome data. This article systematically reviews the literature comparing the outcomes for RARC (comparisons with open radical cystectomy when performed at the same institution) with a focus on operative, complications, oncologic, functional and survival outcomes.

top of page